Jinbo Lee

Jinbo Lee boasts an impressive background with over 25 years of experience in drug discovery and development, specializing in areas such as oncology, metabolic/cardiovascular, CNS, inflammatory, and infectious diseases. His expertise extends to various roles including business development, informatics software for pharmaceutical R&D, medicinal chemistry, and structure-based drug design. Lee holds a PhD in Organic Chemistry from Princeton University and a BS in Chemistry from the University of Science and Technology of China.

Throughout his career, Jinbo Lee has held key positions in prominent organizations, serving as the CEO and Co-founder of Scilligence Corporation, President and Founder of Sage Partner International, Head of Chemistry at Ensemble Therapeutics, Group Leader at Wyeth Pharmaceuticals, and Senior Scientist at Boehringer Ingelheim. He brings vast knowledge of informatics solutions for life sciences R&D and has successfully led multi-discipline teams in drug discovery and development, encompassing medicinal chemists, X-ray crystallographers, molecular modelers, pharmacologists, and DMPK scientists.

Lee's skill set includes setting up and managing external collaborations on a global scale, as well as conducting due diligence, search, and evaluation in the pharmaceutical industry. His profound understanding of medicinal chemistry, structure-based drug design, and prodrug design further solidify his standing as a seasoned professional in the field. Overall, Jinbo Lee is a respected figure with a wealth of experience in various aspects of pharmaceutical research and development.